RUPINDER K GILL

Allopathic & Osteopathic Physicians|Internal Medicine SCOTTSBURG, IN NPI 1770565897

General Payments — all program years on this page

$3,185.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 239
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $360.38 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $360.3821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,346.26111
2019 $773.8660
2020 $119.248
2021 $210.0113
2022 $199.7114
2023 $176.0612
2024 $360.3821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086951483 Novartis Pharmaceuticals Corporation $19.61 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086951487 Novartis Pharmaceuticals Corporation $13.53 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096632803 Novo Nordisk Inc $13.53 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103798506 ABBVIE INC. $16.88 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105617525 AstraZeneca Pharmaceuticals LP $20.06 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105774124 AstraZeneca Pharmaceuticals LP $17.56 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105874211 AstraZeneca Pharmaceuticals LP $20.24 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114674586 Exact Sciences Corporation $17.98 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116366089 GlaxoSmithKline, LLC. $16.16 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116418798 GlaxoSmithKline, LLC. $15.76 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117562566 Amgen Inc. $14.42 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120504916 Alkermes, Inc. $26.27 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131067174 PFIZER INC. $16.22 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131295609 PFIZER INC. $18.36 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132128746 PFIZER INC. $15.67 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135367154 Lilly USA, LLC $16.25 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135381983 Lilly USA, LLC $14.44 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135405932 Lilly USA, LLC $19.62 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135406582 Lilly USA, LLC $13.85 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151065915 Phathom Pharmaceuticals, Inc. $16.76 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153729948 IRONWOOD PHARMACEUTICALS, INC $17.21 04/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.